EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Interventions for reducing anticholinergic medication burden in older adults—a systematic review and meta-analysis

Eve Braithwaite, Oliver M Todd, Abigail Atkin, Rachel Hulatt, Ragy Tadrous, David P Alldred, Munir Pirmohamed, Lauren Walker, Rebecca Lawton, Andrew Clegg

Age and Ageing · 01.09.2023 · 52 (9)

DOI: 10.1093/ageing/afad176 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Age and Ageing, online erschienen am 22.09.2023. Verfasst von Eve Braithwaite und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit for Ageing and Stroke Research, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Quality of Life, Cholinergic Antagonists. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Health, National Institute for Health and Care Excellence, Health Education England.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anticholinergic medications block the neurotransmitter acetylcholine in the brain and peripheral nervous system. Many medications have anticholinergic properties, and the cumulative effect of these medications is termed anticholinergic burden. Increased anticholinergic burden can have short-term side effects such as dry mouth, blurred vision and urinary retention as well as long-term effects including dementia, worsening physical function and falls.

Methods

We carried out a systematic review (SR) with meta-analysis (MA) looking at randomised controlled trials addressing interventions to reduce anticholinergic burden in older adults.

Results

We identified seven papers suitable for inclusion in our SR and MA. Interventions included multi-disciplinary involvement in medication reviews and deprescribing of AC medications. Pooled data revealed no significant difference in outcomes between control and intervention group for falls (OR = 0.76, 95% CI: 0.52–1.11, n = 647), cognition (mean difference = 1.54, 95% CI: −0.04 to 3.13, n = 405), anticholinergic burden (mean difference = 0.04, 95% CI: −0.11 to 0.18, n = 710) or quality of life (mean difference = 0.04, 95% CI: −0.04 to 0.12, n = 461).

Discussion

Overall, there was no significant difference with interventions to reduce anticholinergic burden. As we did not see a significant change in anticholinergic burden scores following interventions, it is likely other outcomes would not change. Short follow-up time and lack of training and support surrounding successful deprescribing may have contributed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeCholinergic AntagonistsHumansAgedAcetylcholineBrainCognition

Stichwörter der Autor:innen

anticholinergic medicationcognitionfallsmeta-analysisolder adultolder peoplesystematic review

Substanzen

Cholinergic AntagonistsAcetylcholine

Autor:innen und Institutionen

  • Academic Unit for Ageing and Stroke Research, University of Leeds, Leeds, UK.
  • Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, UK.
  • Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • School of Healthcare, University of Leeds, Leeds, UK.
  • NIHR Yorkshire & Humber Patient Safety Translational Research Centre, Bradford, UK.
  • Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Förderung

  • Department of Health
  • National Institute for Health and Care Excellence
  • Health Education England
  • Royal College of Physicians UK
  • Health Data Research UK
  • NIHR Leeds Biomedical Research Centre
  • NIHR Applied Research Collaboration Yorkshire & Humber
  • National Institute for Health and Care Research (NIHR) Yorkshire and Humber Patient Safety Translational Research Centre

Zitieren

APA

Braithwaite, E., Todd, O. M., Atkin, A., Hulatt, R., Tadrous, R., Alldred, D. P., Pirmohamed, M., Walker, L., Lawton, R., & Clegg, A. (2023). Interventions for reducing anticholinergic medication burden in older adults—a systematic review and meta-analysis. Age and Ageing, 52(9). https://doi.org/10.1093/ageing/afad176

Vancouver

Braithwaite E, Todd OM, Atkin A, Hulatt R, Tadrous R, Alldred DP, et al. Interventions for reducing anticholinergic medication burden in older adults—a systematic review and meta-analysis. Age and Ageing. 2023;52(9). doi:10.1093/ageing/afad176

BibTeX
@article{Braithwaite2023,
  author = {Braithwaite, Eve and Todd, Oliver M and Atkin, Abigail and Hulatt, Rachel and Tadrous, Ragy and Alldred, David P and Pirmohamed, Munir and Walker, Lauren and Lawton, Rebecca and Clegg, Andrew},
  title = {Interventions for reducing anticholinergic medication burden in older adults—a systematic review and meta-analysis},
  journal = {Age and Ageing},
  year = {2023},
  volume = {52},
  number = {9},
  doi = {10.1093/ageing/afad176}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche